TC Biopharm (Holdings) Plc (TCBP)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Bryan Leland Kobel | CEO & Director | 544.56k | -- | 1979 |
| Mr. Martin Edward Thorp | CFO & Director | 410.52k | -- | 1952 |
| Mr. Christopher Camarra | Executive Vice President of Communications | -- | -- | -- |
| Dr. Lauren Bor Ph.D. | Head of Commercial Development Division | -- | -- | -- |
TC Biopharm (Holdings) Plc
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 41
Description
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
August 26, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
August 9, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission